Obesity leads to MR activation via aldosterone-independent mechanisms such as increased renal tubular expression of ras-related C3 botulinum toxin substrate 1 and increased ROS [78]. The gene discussed is NR3C2; the disease is obesity due to melanocortin 4 receptor deficiency.